CIK 0001735438 · Non-accelerated filer<br>Smaller reporting company
MeiraGTx Holdings plc
Sign in to watch- Ticker
- MGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981448305
- Phone
- 646-860-7985
- Business address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,710,812
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,710,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Mendoza Neil Director | Grant or award · Restricted Share Units | +15,000 | 15,000 | ||
| 2022-06-07 | LEVINE ARNOLD J Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-07 | LEVINE ARNOLD J Director | Grant or award · Restricted Share Units | +15,000 | 15,000 | ||
| 2022-06-07 | Indyk Martin Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-07 | Indyk Martin Director | Grant or award · Restricted Share Units | +15,000 | 15,000 | ||
| 2022-06-07 | Harris Keith R. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-07 | Harris Keith R. Director | Grant or award · Restricted Share Units | +20,000 | 20,000 | ||
| 2022-06-07 | MARCUS JOEL S Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-07 | MARCUS JOEL S Director | Grant or award · Restricted Share Units | +15,000 | 15,000 | ||
| 2022-06-07 | Hukkelhoven Ellen Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-07 | Hukkelhoven Ellen Director | Grant or award · Restricted Share Units | +15,000 | 15,000 | ||
| 2022-06-03 | Zeldin Robert K CHIEF MEDICAL OFFICER | Purchase | +4,994 | $7.90 | $39K | 4,994 |
| 2022-06-03 | Zeldin Robert K CHIEF MEDICAL OFFICER | Purchase | +6 | $7.89 | $47 | 5,000 |
| 2022-05-25 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Purchase | +1,000 | $7.94 | $8K | 1,000 |
| 2022-04-25 | Yu Debra Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-01-08 | Forbes Alexandria President and CEO | Option exercise | +97,500 | 1,160,781 | ||
| 2022-01-08 | Forbes Alexandria President and CEO | Shares withheld for taxes | −51,554 | $21.53 | $1.1M | 1,109,227 |
| 2022-01-08 | Forbes Alexandria President and CEO | Option exercise · Restricted Share Units | −97,500 | 97,500 | ||
| 2022-01-08 | Giroux Richard CFO & COO | Option exercise | +75,000 | 888,318 | ||
| 2022-01-08 | Giroux Richard CFO & COO | Shares withheld for taxes | −39,657 | $21.53 | $854K | 848,661 |
Page 15 of 21 · 411 trades